insights_auto
Why is GANX down 2.86%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$1.02
arrow_downward
-2.86%(-0.030) 1D
Nov 20, 12:59:53 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.02
High
$1.10
Low
$1.01
Mkt. cap
45.42M
Avg. vol.
690.72K
Volume
344.72K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.02
High
$1.10
Low
$1.01
Mkt. cap
45.42M
Avg. vol.
690.72K
Volume
344.72K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
Quantisnow
·
2 days ago
GANX: Gain Therapeutics Inc. filed SEC Form 8-K: Other Events
Investing.com
·
2 days ago
Gain Therapeutics reports 12-month rexaceract trial results
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com